Central Serous Chorioretinopathy: Update on Pathophysiology and Treatment

2013/02/11 by Benjamin Nicholson, Jason Noble, Farzin Forooghian +1 · 657 citations
Medicine · Neuroscience · #Choroid #Fluorescein angiography #Glaucoma and retinal disorders #Indocyanine green #Indocyanine green angiography #Medicine #Microperimetry #Neuroscience #Ophthalmology #Optical coherence tomography #Pathology #Retina #Retinal Diseases and Treatments #Retinal Imaging and Analysis #Serous fluid #Visual acuity

paper · open access · doi:10.1016/j.survophthal.2012.07.004

published in Survey of Ophthalmology 58(2), 103-126 (Elsevier BV)

openalex publication_date 2013/02/11 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/31

Cited by

• Responsiveness of eyes with polypoidal choroidal vasculopathy with choroidal hyperpermeability to intravitreal ranibizumab. [europepmc]
• Comparing half-dose photodynamic therapy with high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy (the PLACE trial): study protocol for a randomized controlled trial. [europepmc]
• Optical Coherence Tomography Angiography in Central Serous Chorioretinopathy. [europepmc]
• Interventions for central serous chorioretinopathy: a network meta-analysis. [europepmc]
• Nondamaging Retinal Laser Therapy: Rationale and Applications to the Macula. [europepmc]
• Structural Changes of Inner and Outer Choroid in Central Serous Chorioretinopathy Determined by Optical Coherence Tomography. [europepmc]
• Subfoveal Choroidal Thickness in Central Serous Chorioretinopathy: A Meta-Analysis. [europepmc]
• Clinical features of serous retinopathy observed with cobimetinib in patients with BRAF-mutated melanoma treated in the randomized coBRIM study. [europepmc]
• Fluorescence lifetime imaging ophthalmoscopy. [europepmc]
• Short-Term Choriocapillaris Changes in Patients with Central Serous Chorioretinopathy after Half-Dose Photodynamic Therapy. [europepmc]
• Clinical characteristics of chronic central serous chorioretinopathy patients with insufficient response to reduced-settings photodynamic therapy. [europepmc]
• Pachychoroid disease. [europepmc]
• Review of clinical approaches in fluorescence lifetime imaging ophthalmoscopy. [europepmc]
• Choroidal biomarkers. [europepmc]
• "Double-layer sign" on spectral domain optical coherence tomography in pachychoroid spectrum disease. [europepmc]
• Clinical spectrum of severe chronic central serous chorioretinopathy and outcome of photodynamic therapy. [europepmc]
• Central serous chorioretinopathy with and without steroids: A multicenter survey. [europepmc]
• FUNDUS AUTOFLUORESCENCE PATTERNS IN CENTRAL SEROUS CHORIORETINOPATHY. [europepmc]
• Association between visual function and the integrity of residual ellipsoid zone in resolved central serous chorioretinopathy. [europepmc]
• Genome-wide association analyses identify two susceptibility loci for pachychoroid disease central serous chorioretinopathy. [europepmc]
• Tight Junctions of the Outer Blood Retina Barrier. [europepmc]
• Risk of Recurrence and Transition to Chronic Disease in Acute Central Serous Chorioretinopathy. [europepmc]
• Acute-onset central serous retinopathy after immunization with COVID-19 mRNA vaccine. [europepmc]
• Incidence of central serous chorioretinopathy (2011-2018): a nationwide population-based cohort study of Japan. [europepmc]
• Central serous chorioretinopathy: updates in the pathogenesis, diagnosis and therapeutic strategies. [europepmc]